Perceived Symptoms, Mental Health and Quality of Life after Hospitalization in COVID-19 Patients

Fradelos, Εvangelos C.; Boutlas, Stylianos; Tsimitrea, Eleni; Sistou, Alexandra; Tourlakopoulos, Konstantinos; Papathanasiou, Ioanna V.; Gourgoulianis, Konstantinos

doi:10.3390/jpm12050728

Cited by 7 publications

(4 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Some studies revealed reduced QoL a few weeks after hospital discharge [14], possibly due to decreased mobility [15]. On the other hand, 145 previously hospitalized Greek patients with COVID-19 reported good QoL compared with the general population; however, only a minority of participants experienced severe disease [16]. Moreover, as was shown in a recent large meta-analysis of more than 500 studies regarding long COVID, only 16% and 10% of them focused on the QoL and work aspects, respectively [17].…”

Section: Introductionmentioning

confidence: 99%

Brain Fog and Quality of Life at Work in Non-Hospitalized Patients after COVID-19

Chatys-Bogacka

Mazurkiewicz

Słowik

et al. 2022

IJERPH

View full text Add to dashboard Cite

Background: There is still a need for studies on the quality of life (QoL) at work among COVID-19 survivors. Therefore, we aimed to evaluate the association between the brain fog symptoms and the QoL at work in non-hospitalized patients with previous SARS-CoV-2 infection. Methods: Three hundred non-hospitalized patients (79.33% women; median age, 36 years; interquartile range, 30–48 years) were included in the final analysis. An anonymous neuropsychological questionnaire containing eight different questions on the presence of brain fog symptoms in four time intervals, i.e., pre-COVID-19 and 0–4, 4–12, and >12 weeks after infection, was retrospectively introduced to patients and staff of the University Hospital in Krakow. Additionally, a four-point Likert scale was used to evaluate QoL at work in four time periods. Included were participants aged ≥18 years in whom the diagnosis of COVID-19 was confirmed by the RT-PCR from nasopharyngeal swab and the first symptoms occurred no earlier than 3 months before the completion of the questionnaire. Results: Before SARS-CoV-2 infection, 28.00% (n = 84) of patients reported poor QoL at work. Within 4, 4–12, and >12 weeks after infection, a decrease in QoL was observed in 75.67% (n = 227), 65.00% (n = 195), and 53.66% (n = 161) of patients, respectively (p < 0.001). With increasing deterioration of the QoL at work, the number of brain fog symptoms increased, and patients with severe QoL impairment exhibited a median of five symptoms for <4, 4–12, and >12 weeks post-COVID-19. In the multivariable logistic regression model, predictors of the deterioration of the QoL at work depended on the time from COVID-19 onset; in the acute phase of the disease (<4 weeks), it was predicted by impairment in remembering information from the past (OR 1.88, 95%CI: 1.18–3.00, p = 0.008) and multitasking (OR 1.96, 95%CI: 1.48–2.58, p < 0.001). Furthermore, an impairment in the QoL at work 4–12 weeks and >12 weeks after COVID-19 was independently associated with age (OR 0.46, 95%CI: 0.25–0.85, p = 0.014 and OR 1.03, 95%CI: 1.01–1.05, p = 0.025, respectively), problems with multitasking (OR 2.05, 95%CI: 1.40–3.01, p < 0.001 and OR 1.75, 95%CI: 1.15–2.66, p = 0.009, respectively), answering questions in an understandable/unambiguous manner (OR 1.99, 95%CI: 1.27–3.14, p = 0.003 and OR 2.00, 95%CI: 1.47–2.36, p = 0.001, respectively), and, only for the >12 week interval, problems with remembering information from the past (OR 2.21, 95%CI: 1.24–3.92, p = 0.007). Conclusions: Certain brain fog symptoms, such as impaired memory or multitasking, are predictors of a poorer QoL at work not only during the acute phase of COVID-19 but also within more than 12 weeks after the onset of infection.

show abstract

Section: Introductionmentioning

confidence: 99%

Brain Fog and Quality of Life at Work in Non-Hospitalized Patients after COVID-19

Chatys-Bogacka

Mazurkiewicz

Słowik

et al. 2022

IJERPH

View full text Add to dashboard Cite

show abstract

“…Este dato es similar a lo reportado en población China en donde se reporta un impacto en el 53 % de la muestra. No obstante, es mayor al 24.7 % reportado en población española por Parrado-González y León-Jariego (2020) y al 11.7 % reportado en población griega por Fradelos et al (2022).…”

Section: Discussionunclassified

Síntomas psicológicos durante la pandemia por COVID-19 en Nuevo León

Peña

Aguirre

Vázquez

2023

PSIM

View full text Add to dashboard Cite

Se evaluaron los síntomas psicológicos durante el periodo de confinamiento por COVID-19 y su relación con el impacto del evento percibido en Nuevo León, México. Fue un estudio transversal de tipo correlacional donde participaron 1872 personas (34.7 % hombres y 65.3 % mujeres). Se utilizó el Inventario de Síntomas Revisado para evaluar el grado de malestar emocional y la Escala de Impacto de Evento revisada para evaluar sintomatología del estrés postraumático. El 56.5 % de la muestra presentó estrés postraumático. Existe relación entre la severidad global del malestar emocional y las dimensiones de estrés, edad y grado en que se practica la religión. Además, se encontraron diferencias significativas por sexo en todas las sub dimensiones del malestar emocional, siendo mayor la diferencia en somatizaciones. Por grupos de edad, también existen diferencias significativas, destacando el malestar emocional y el estrés postraumático, siendo mayor en los menores a 35 años. Tener un diagnóstico positivo de COVID-19 generó mayores somatizaciones, mientras que contar con alguien cercano que haya fallecido por causas relacionadas al mismo incrementa toda la sintomatología psicológica y el estrés postraumático. El inicio del confinamiento impactó emocionalmente a la población, siendo más vulnerables los grupos de mujeres y los menores de 35 años.

show abstract

“…Each domain was scored on a 0-100 metric scale, with a higher score reflecting better health [15]. A mean score of 50 was considered a normative value for all subscales [16].…”

Section: Medical Outcomes Study 36 -Item Short-form Health Surveymentioning

confidence: 99%

Long Covid-19 Syndrome: the Prevalence of Neuropsychiatric Symptoms in Patients with Olfactory Disorders

Santos Sales,

Beiral Hammerle,

da Silva Souza

et al. 2023

View full text Add to dashboard Cite

Background: Among the frequently reported symptoms in long-term COVID-19 syndrome, we can highlight olfactory disorders depression, anxiety, and fatigue. OD can affect people's physical and mental health and can lead to neuropsychiatric symptoms. Objective: Determine the prevalence of symptoms of depression, anxiety, and fatigue in patients with olfactory disorders induced by long-term COVID-19; and investigate this impact on the quality of life. Methods: The study included 30 patients with confirmed long-term COVID-19, with persistent complaints of olfactory dysfunction. OD was evaluated by the connecticut smell test. Neuropsychiatric disorders were evaluated by the fatigue severity and hospital anxiety and depression scales. Quality of life was accessed using the SF-36. Results: 70% of the patients had different degrees of hyposmia and 20% had anosmia. The most prevalent symptom was depression with 66.7% of the sample. More than half of patients also had symptoms of anxiety and fatigue (53,3% both). The most affected dimensions of SF-36 were emotional, vitality, role physical and mental health (36.6 ± 44.0, 44.3 ± 28.7, 47.5 ± 42.7, 49.8 ± 24.7 respectively). There was a moderate negative correlation between symptoms of depression and the physical role and mental health dimension. There was a moderate negative correlation between anxiety and general health, vitality, social functioning, and mental health dimensions. Symptoms of fatigue obtained a moderate negative correlation in the physical function dimension. Conclusion: The prevalence of symptoms of depression, anxiety and fatigue is high in patients with olfactory disorders induced by long-term COVID-19, with a negative impact on the quality of life of these patients, highlighting the role emotional aspect.

show abstract

Perceived Symptoms, Mental Health and Quality of Life after Hospitalization in COVID-19 Patients

Cited by 7 publications

References 34 publications

Brain Fog and Quality of Life at Work in Non-Hospitalized Patients after COVID-19

Brain Fog and Quality of Life at Work in Non-Hospitalized Patients after COVID-19

Síntomas psicológicos durante la pandemia por COVID-19 en Nuevo León

Long Covid-19 Syndrome: the Prevalence of Neuropsychiatric Symptoms in Patients with Olfactory Disorders

Contact Info

Product

Resources

About